Literature DB >> 19836306

Circulating tumour cells as more than prognostic markers.

Justin Stebbing, Long R Jiao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19836306     DOI： 10.1016/S1470-2045(09)70260-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Circulating tumour cells: their utility in cancer management and predicting outcomes.

Authors:  Matthew G Krebs; Jian-Mei Hou; Tim H Ward; Fiona H Blackhall; Caroline Dive
Journal:  Ther Adv Med Oncol       Date:  2010-11       Impact factor: 8.168

2.  Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells.

Authors:  Virgílio Souza E Silva; Ludmilla Thomé Domingos Chinen; Emne A Abdallah; Aline Damascena; Jociana Paludo; Rubens Chojniak; Aldo Lourenço Abbade Dettino; Celso Abdon Lopes de Mello; Vanessa S Alves; Marcello F Fanelli
Journal:  Onco Targets Ther       Date:  2016-12-13       Impact factor: 4.147

3.  Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.

Authors:  Satomi Yagi; Yasuhiro Koh; Hiroaki Akamatsu; Kuninobu Kanai; Atsushi Hayata; Nahomi Tokudome; Keiichiro Akamatsu; Katsuya Endo; Seita Nakamura; Masayuki Higuchi; Hisashige Kanbara; Masanori Nakanishi; Hiroki Ueda; Nobuyuki Yamamoto
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

4.  The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study.

Authors:  Justin Stebbing; Rachel Payne; Justine Reise; Adam E Frampton; Miranda Avery; Laura Woodley; Angelo Di Leo; Marta Pestrin; Jonathan Krell; R Charles Coombes
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.